Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases

References

• Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil Extracellular Traps Kill Bacteria. Sci. 2004;303(5663):1532–22. doi:10.1126/science.1092385.
   PubMed Web of Science ®Google Scholar
• Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853–62. doi:10.1084/jem.20100239.
   PubMed Web of Science ®Google Scholar
• Tambralli A, Gockman K, Knight JS. NETs in APS: Current knowledge and future perspectives. Curr Rheumatol Rep. 2020;22(10):67. doi:10.1007/s11926-020-00936-1.
   PubMed Web of Science ®Google Scholar
• Li RHL, Tablin F. A comparative review of neutrophil extracellular traps in sepsis. Front Vet Sci. 2018;5:291. doi:10.3389/fvets.2018.00291.
   PubMed Web of Science ®Google Scholar
• Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134–47. doi:10.1038/nri.2017.105.
   PubMed Web of Science ®Google Scholar
• Bosmann M, Ward PA. Protein-based therapies for acute lung injury: Targeting neutrophil extracellular traps. Expert Opin Ther Targets. 2014;18(6):703–14. doi:10.1517/14728222.2014.902938.
   PubMed Web of Science ®Google Scholar
• Morán G, Uberti B, Quiroga J. Role of cellular metabolism in the formation of neutrophil extracellular traps in airway diseases. Front Immunol. 2022;13:1–12. doi:10.3389/fimmu.2022.850416.
   Web of Science ®Google Scholar
• Kenny EF, Herzig A, Krüger R, Muth A, Mondal S, Thompson PR, Brinkmann V, von Bernuth H, Zychlinsky A. Diverse stimuli engage different neutrophil extracellular trap pathways. Elife. 2017;6:e24437. doi:10.7554/eLife.24437.
   PubMed Web of Science ®Google Scholar
• Muñoz LE, Boeltz S, Bilyy R, Schauer C, Mahajan A, Widulin N, Grüneboom A, Herrmann I, Boada E, Rauh M, et al. Neutrophil Extracellular Traps Initiate Gallstone Formation. Immunity. 2019;51(3):443–50.e4. doi:10.1016/j.immuni.2019.07.002.
   PubMed Web of Science ®Google Scholar
• Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin Rev Allergy Immunol. 2021;61(2):194–211. doi:10.1007/s12016-020-08804-7.
   PubMed Web of Science ®Google Scholar
• Barnado A, Crofford LJ, Oates JC. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J Leukoc Biol. 2016;99(2):265–78. doi:10.1189/jlb.5BT0615-234R.
   PubMed Web of Science ®Google Scholar
• Parker H, Dragunow M, Hampton MB, Kettle AJ, Winterbourn CC. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J Leukoc Biol. 2012;92(4):841–49. doi:10.1189/jlb.1211601.
   PubMed Web of Science ®Google Scholar
• Neeli I, Radic M. Opposition between PKC isoforms regulates histone deimination and neutrophil extracellular chromatin release. Front Immunol. 2013;4:1–9. doi:10.3389/fimmu.2013.00038.
   PubMed Web of Science ®Google Scholar
• Neubert E, Meyer D, Rocca F, Günay G, Kwaczala-Tessmann A, Grandke J, Senger-Sander S, Geisler C, Egner A, Schön MP, et al. Chromatin swelling drives neutrophil extracellular trap release. Nat Commun. 2018;9(1):3767. doi:10.1038/s41467-018-06263-5.
   PubMedGoogle Scholar
• Thiam HR, Wong SL, Qiu R, Kittisopikul M, Vahabikashi A, Goldman AE, Goldman RD, Wagner DD, Waterman CM. NETosis proceeds by cytoskeleton and endomembrane disassembly and PAD4-mediated chromatin decondensation and nuclear envelope rupture. Proc Natl Acad Sci U S A. 2020;117(13):7326–37. doi:10.1073/pnas.1909546117.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009;184(2):205–13. doi:10.1083/jcb.200806072.
   PubMed Web of Science ®Google Scholar
• Chirivi RGS, Jenniskens GJ, Raats JMH. Anti-Citrullinated Protein Antibodies as Novel Therapeutic Drugs in Rheumatoid Arthritis. J Clin Cell Immunol. 2013;1(S6):1–13. doi:10.4172/2155-9899.S6-006.
   Google Scholar
• Chirivi RGS, Van Rosmalen JWG, Van der Linden M, Euler M, Schmets G, Bogatkevich G, Kambas K, Hahn J, Braster Q, Soehnlein O, et al. Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases. Cell Mol Immunol. 2021;18(6):1528–44. doi:10.1038/s41423-020-0381-3.
   PubMed Web of Science ®Google Scholar
• Merchant AM, Zhu Z, Yuan JQ, Goddard A, Adams CW, Presta LG, Carter P. An efficient route to human bispecific IgG. Nat Biotechnol. 1998;16(7):677–81. doi:10.1038/nbt0798-677.
   PubMed Web of Science ®Google Scholar
• Van Der Linden M, Westerlaken GHA, Van Der Vlist M, Van Montfrans J, Meyaard L. Differential signalling and kinetics of neutrophil extracellular trap release revealed by quantitative live imaging. Sci Rep. 2017;7(1):6529. doi:10.1038/s41598-017-06901-w.
   PubMedGoogle Scholar
• Raposo B, Afonso M, Israelsson L, Wähämaa H, Stålesen R, Wermeling F, Haj Hensvold A, Grönwall C, Rethi B, Klareskog L, et al. Divergent and dominant anti- ­ inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development. Ann Rheum Dis. 2023;82(5):724–26. doi:10.1136/ard-2022-223417.
   PubMed Web of Science ®Google Scholar
• He Y, Ge C, Moreno-Giró À, Xu B, Beusch CM, Sandor K, Su J, Cheng L, Lönnblom E, Lundqvist C, et al. A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis. Nat Commun. 2023;14(1):1–19. doi:10.1038/s41467-023-36257-x.
   PubMed Web of Science ®Google Scholar
• Gomez AM, Brewer RC, Moon J-S, Acharya S, Kongpachith S, Wang Q, Jahanbani S, Wong HH, Lanz TV, Love ZZ, et al. Anti-citrullinated protein antibodies with diverse specificities ameliorate collagen antibody-induced arthritis in a time-dependent manner. Arthritis Rheumatol. 2023; online ahead of print. doi:10.1002/art.42679.
   Web of Science ®Google Scholar
• Sur Chowdhury C, Giaglis S, Walker UA, Buser A, Hahn S, Hasler P. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther. 2014;16(3):R122. doi:10.1186/ar4579.
   PubMed Web of Science ®Google Scholar
• Bach M, Moon J, Moore R, Pan T, Nelson JL, Lood C. A neutrophil activation biomarker panel in prognosis and monitoring of patients with rheumatoid arthritis. Arthritis Rheumatol. 2020;72(1):47–56. doi:10.1002/art.41062.
   PubMed Web of Science ®Google Scholar
• Spengler J, Lugonja B, Ytterberg AJ, Zubarev RA, Creese AJ, Pearson MJ, Grant MM, Milward M, Lundberg K, Buckley CD, et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol. 2015;67(12):3135–45. doi:10.1002/art.39313.
   PubMed Web of Science ®Google Scholar
• Carmona-Rivera C, Carlucci PM, Goel RR, James E, Brooks SR, Rims C, Hoffmann V, Fox DA, Buckner JH, Kaplan MJ. Neutrophil extracellular traps mediate articular cartilage damage and enhance cartilage component immunogenicity in rheumatoid arthritis. JCI Insight. 2020;5(13):e139388. doi:10.1172/jci.insight.139388.
   PubMed Web of Science ®Google Scholar
• Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178):178ra40. doi:10.1126/scitranslmed.3005580.
   PubMed Web of Science ®Google Scholar
• van der Linden M, Meyaard L. Fine-tuning neutrophil activation: Strategies and consequences. Immunol Lett. 2016;178:3–9. doi:10.1016/j.imlet.2016.05.015.
   PubMed Web of Science ®Google Scholar
• Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22(2):146–53. doi:10.1038/nm.4027.
   PubMed Web of Science ®Google Scholar
• Kraaij T, Tengström FC, Kamerling SWA, Pusey CD, Scherer HU, Toes REM, Rabelink TJ, van Kooten C, Teng YKO. A novel method for high-throughput detection and quantification of neutrophil extracellular traps reveals ROS-independent NET release with immune complexes. Autoimmun Rev. 2016;15(6):577–84. doi:10.1016/j.autrev.2016.02.018.
   PubMed Web of Science ®Google Scholar
• Behnen M, Leschczyk C, Möller S, Batel T, Klinger M, Solbach W, Laskay T. Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via FcγRIIIB and Mac-1. J Immunol. 2014;193(4):1954–65. doi:10.4049/jimmunol.1400478.
   PubMed Web of Science ®Google Scholar
• Limon M. The assessment of rheumatoid factor levels and hemogram parameters as predictors for rheumatologic disease. Int J Of Rheum Dis. 2023;26(6):1041–47. doi:10.1111/1756-185X.14683.
   PubMed Web of Science ®Google Scholar
• Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ. 2012;345(sep06 2):e5244–e5244. doi:10.1136/bmj.e5244.
   PubMedGoogle Scholar
• Boeters DM, Mangnus L, Ajeganova S, Lindqvist E, Svensson B, Toes REM, Trouw LA, Huizinga TWJ, Berenbaum F, Morel J, et al. The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical. Arthritis Res Ther. 2017;19(1):1–10. doi:10.1186/s13075-017-1324-y.
   PubMedGoogle Scholar
• Willemze A, Böhringer S, Knevel R, Levarht EWN, Stoeken-Rijsbergen G, Houwing-Duistermaat JJ, Van Der Helm-van Mil AHM, Huizinga TWJ, Toes REM, Trouw LA. The ACPA recognition profile and subgrouping of ACPA-positive RA patients. Ann Rheum Dis. 2012;71(2):268–74. doi:10.1136/annrheumdis-2011-200421.
   PubMed Web of Science ®Google Scholar
• Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is a silent process. J Immunol. 2013;191(5):2647–56. doi:10.4049/jimmunol.1300436.
   PubMed Web of Science ®Google Scholar
• Russell V, Brana M, Pompilio D, Ambrosi G, Andreetta F, Venturini E, Chalidou A, Manni ME. Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide. Eur Respir J. 2018;52:A1048. doi:10.1183/13993003.congress-2018.PA1048.
   Web of Science ®Google Scholar
• Kaplan MJ, Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol. 2012;189(6):2689–95. doi:10.4049/jimmunol.1201719.
   PubMed Web of Science ®Google Scholar
• O’Neil LJ, Barrera-Vargas A, Sandoval-Heglund D, Merayo-Chalico J, Aguirre-Aguilar E, Aponte AM, Ruiz-Perdomo Y, Gucek M, El-Gabalaawy H, Fox DA, et al. Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis. Sci Adv. 2020;6(44):eabd2688. doi:10.1126/sciadv.abd2688.
   PubMed Web of Science ®Google Scholar
• Li C, Zuo Y, Zhang S, Makris UE, Karp DR, Li Z. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients. Chin Med J (Engl). 2022;135(6):658–64. doi:10.1097/CM9.0000000000001964.
   PubMed Web of Science ®Google Scholar
• Casey KA, Smith MA, Sinibaldi D, Seto NL, Playford MP, Wang X, Carlucci PM, Wang L, Illei G, Yu B, et al. Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus. Arthritis Rheumatol. 2021;73(3):459–71. doi:10.1002/art.41518.
   PubMedGoogle Scholar
• Tian Y, Russo RM, Li Y, Karmakar M, Liu B, Puskarich MA, Jones AE, Stringer KA, Standiford TJ, Alam HB. Serum citrullinated histone H3 concentrations differentiate patients with septic verses non-septic shock and correlate with disease severity. Infection. 2021;49(1):83–93. doi:10.1007/s15010-020-01528-y.
   PubMed Web of Science ®Google Scholar
• Kuczia P, Zuk J, Iwaniec T, Soja J, Dropinski J, Malesa-Wlodzik M, Zareba L, Bazan JG, Undas A, Bazan-Socha S. Citrullinated histone H3, a marker of extracellular trap formation, is increased in blood of stable asthma patients. Clin Transl Allergy. 2020;10(1):31. doi:10.1186/s13601-020-00337-8.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Yalavarthi S, Navaz SA, Hoy CK, Harbaugh A, Gockman K, Zuo M, Madison JA, Shi H, Kanthi Y, et al. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight. 2021;6:e150111. doi:10.1172/jci.insight.150111.
   PubMed Web of Science ®Google Scholar
• Wong SL, Demers M, Martinod K, Gallant M, Wang Y, Goldfine AB, Kahn CR, Wagner DD. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med. 2015;21(7):815–19. doi:10.1038/nm.3887.
   PubMed Web of Science ®Google Scholar
• Martinod K, Demers M, Fuchs TA, Wong SL, Brill A, Gallant M, Hu J, Wang Y, Wagner DD. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A. 2013;110(21):8674–79. doi:10.1073/pnas.1301059110.
   PubMed Web of Science ®Google Scholar
• Liu Y, Carmona-Rivera C, Moore E, Seto NL, Knight JS, Pryor M, Yang ZH, Hemmers S, Remaley AT, Mowen KA, et al. Myeloid-specific deletion of peptidylarginine deiminase 4 mitigates atherosclerosis. Front Immunol. 2018;9:1–13. doi:10.3389/fimmu.2018.01680.
   PubMed Web of Science ®Google Scholar
• Biron BM, Chung CS, O’Brien XM, Chen Y, Reichner JS, Ayala A. Cl-Amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model. J Innate Immun. 2017;9(1):22–32. doi:10.1159/000448808.
   PubMed Web of Science ®Google Scholar
• Chumanevich AA, Causey CP, Knuckley BA, Jones JE, Poudyal D, Chumanevich AP, Davis T, Matesic LE, Thompson PR, Hofseth LJ. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am J Physiol - Gastrointest Liver Physiol. 2011;300(6):G929–G38. doi:10.1152/ajpgi.00435.2010.
   PubMed Web of Science ®Google Scholar
• Raup-Konsavage WM, Wang Y, Wang WW, Feliers D, Ruan H, Reeves WB. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int. 2018;93(2):365–74. doi:10.1016/j.kint.2017.08.014.
   PubMed Web of Science ®Google Scholar
• Martinod K, Witsch T, Erpenbeck L, Savchenko A, Hayashi H, Cherpokova D, Gallant M, Mauler M, Cifuni SM, Wagner DD. Peptidylarginine deiminase 4 promotes age-related organ fibrosis. J Exp Med. 2017;214(2):439–58. doi:10.1084/jem.20160530.
   PubMed Web of Science ®Google Scholar
• Seri Y, Shoda H, Suzuki A, Matsumoto I, Sumida T, Fujio K, Yamamoto K. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model. Sci Rep. 2015;5(1):1–7. doi:10.1038/srep13041.
   Google Scholar
• Knight JS, Zhao W, Luo W, Subramanian V, O’Dell AA, Yalavarthi S, Hodgin JB, Eitzman DT, Thompson PR, Kaplan MJ. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest. 2013;123(7):2981–93. doi:10.1172/JCI67390.
   PubMed Web of Science ®Google Scholar
• Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107(21):9813–18. doi:10.1073/pnas.0909927107.
   PubMed Web of Science ®Google Scholar
• Leffler J, Martin M, Gullstrand B, Tydén H, Lood C, Truedsson L, Bengtsson AA, Blom AM. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol. 2012;188(7):3522–31. doi:10.4049/jimmunol.1102404.
   PubMed Web of Science ®Google Scholar
• Li M, Lin C, Deng H, Strnad J, Bernabei L, Vogl DT, Burke JJ, Nefedova Y. A novel peptidylarginine deiminase 4 (PAD4) inhibitor BMS-P5 blocks formation of neutrophil extracellular traps and delays progression of multiple myeloma. Mol Cancer Ther. 2020;19(7):1530–38. doi:10.1158/1535-7163.MCT-19-1020.
   PubMed Web of Science ®Google Scholar
• Ai P, Pan H, Chen K, Zheng J, Gao Z, Jin G. Viral mimetic poly(I: C) induces neutrophil extracellular traps via PAD4 to promote inflammation and thrombosis. Biochem Biophys Res Commun. 2021;565:64–71. doi:10.1016/j.bbrc.2021.05.091.
   PubMed Web of Science ®Google Scholar
• Perdomo J, Leung HHL, Ahmadi Z, Yan F, Chong JJH, Passam FH, Chong BH. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun. 2019;10(1):1322. doi:10.1038/s41467-019-09160-7.
   PubMedGoogle Scholar
• Shrestha B, Ito T, Kakuuchi M, Totoki T, Nagasato T, Yamamoto M, Maruyama I. Recombinant thrombomodulin suppresses histone-induced neutrophil extracellular trap formation. Front Immunol. 2019;10:2535. doi:10.3389/fimmu.2019.02535.
   PubMed Web of Science ®Google Scholar
• Menegazzo L, Scattolini V, Cappellari R, Bonora BM, Albiero M, Bortolozzi M, Romanato F, Ceolotto G, Vigili de Kreutzeberg S, Avogaro A, et al. The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo. Acta Diabetol. 2018;55(6):593–601. doi:10.1007/s00592-018-1129-8.
   PubMed Web of Science ®Google Scholar
• Silva CMS, Wanderley CWS, Veras FP, Sonego F, Nascimento DC, Gonçalves AV, Martins TV, Cólon DF, Borges VF, Brauer VS, et al. Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation. Blood. 2021;138(25):2702–13. doi:10.1182/blood.2021011525.
   PubMed Web of Science ®Google Scholar